Clinical Trials Logo

Phaeochromocytoma clinical trials

View clinical trials related to Phaeochromocytoma.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT01941849 Withdrawn - Paraganglioma Clinical Trials

Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma

VIBRaNT
Start date: October 2014
Phase: Phase 1
Study type: Interventional

The phase I trial aims to determine the recommended phase II dose (RP2D) of vandetanib in combination with standard radiation therapy, 131I-mIBG, in patients with advanced phaeochromocytoma (phaeo) and paraganglioma (PG) by assessing the safety and tolerability of the combination treatment.